Akorn Pharmaceuticals

Akorn Investor Relations

SEC Filings

Filing date Form Description Filing Group View
4

Statement of changes in beneficial ownership of securities

3,4,5
4

Statement of changes in beneficial ownership of securities

3,4,5
4

Statement of changes in beneficial ownership of securities

3,4,5
SC TO-I

Tender offer schedule and amendment filed by the issuer.

Other
RW

Withdrawal of registration statement filed under the Securities Act

Other
RW

Withdrawal of registration statement filed under the Securities Act

Other